Xudong Zhu Selected Research

Laccase

7/2009	A copper-responsive factor gene CUF1 is required for copper induction of laccase in Cryptococcus neoformans.
11/2006	The Hsp70 member, Ssa1, acts as a DNA-binding transcriptional co-activator of laccase in Cryptococcus neoformans.
11/2003	A CLC-type chloride channel gene is required for laccase activity and virulence in Cryptococcus neoformans.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xudong Zhu Research Topics

Disease

28	Neoplasms (Cancer) 05/2022 - 02/2003
12	Inflammation (Inflammations) 02/2022 - 08/2002
11	Neoplasm Metastasis (Metastasis) 10/2022 - 02/2003
10	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 01/2019
9	Breast Neoplasms (Breast Cancer) 06/2022 - 12/2005
7	Prostatic Neoplasms (Prostate Cancer) 11/2021 - 10/2012
7	Hypersensitivity (Allergy) 11/2018 - 08/2011
6	Stomach Neoplasms (Stomach Cancer) 01/2022 - 06/2003
6	Infections 10/2020 - 11/2003
5	Carcinogenesis 01/2022 - 10/2012
5	Obesity 01/2022 - 02/2014
5	Starvation 01/2019 - 10/2004
4	Hepatocellular Carcinoma (Hepatoma) 10/2022 - 04/2013
4	Cryptococcosis 06/2019 - 11/2003
3	Insulin Resistance 01/2022 - 02/2014
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2017
3	Necrosis 10/2019 - 09/2009
2	Triple Negative Breast Neoplasms 01/2022 - 01/2019
2	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2022 - 11/2021
2	Colonic Neoplasms (Colon Cancer) 01/2021 - 10/2020
2	Pathologic Processes 11/2020 - 01/2020
2	Cicatrix (Scar) 10/2020 - 10/2015
2	Cardiomyopathies (Cardiomyopathy) 01/2020 - 01/2019
2	Heart Failure 01/2020 - 01/2017
2	Cardiovascular Diseases (Cardiovascular Disease) 10/2019 - 12/2015
2	Atherosclerosis 01/2019 - 09/2009
2	Disease Resistance 01/2019 - 12/2016
2	Reperfusion Injury 10/2012 - 09/2012
2	Ischemia 10/2012 - 09/2012
2	Carcinoma (Carcinomatosis) 06/2003 - 02/2003
1	Urinary Bladder Neoplasms (Bladder Cancer) 05/2022
1	Hyperthermia 05/2022
1	Dysentery 02/2022
1	Diarrhea 02/2022
1	Rheumatoid Arthritis 02/2022
1	Lymphatic Metastasis 01/2022
1	Adenocarcinoma 01/2022
1	Acute-Phase Reaction 01/2022
1	Overnutrition 01/2022
1	Atherosclerotic Plaque (Atheroma) 01/2022
1	Body Weight (Weight, Body) 01/2022
1	Non-alcoholic Fatty Liver Disease 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 10/2021

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2002
12	Scavenger Receptors (Scavenger Receptor)IBA 01/2021 - 11/2011
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2018
6	Messenger RNA (mRNA)IBA 06/2022 - 02/2003
5	LipidsIBA 01/2022 - 01/2009
5	Tyrosine Kinase InhibitorsIBA 01/2022 - 01/2019
4	Biological ProductsIBA 05/2022 - 10/2004
4	Transcription Factors (Transcription Factor)IBA 01/2021 - 12/2005
4	Pattern Recognition ReceptorsIBA 01/2021 - 08/2016
4	Pharmaceutical PreparationsIBA 01/2021 - 01/2017
4	Congo RedIBA 01/2018 - 12/2016
4	Glucose (Dextrose)FDA LinkGeneric 01/2016 - 10/2004
4	CopperIBA 08/2011 - 11/2006
3	Immune Checkpoint InhibitorsIBA 10/2022 - 10/2020
3	major vault proteinIBA 01/2022 - 01/2019
3	Circular RNAIBA 01/2022 - 11/2020
3	Small Interfering RNA (siRNA)IBA 01/2022 - 01/2019
3	abirateroneIBA 11/2021 - 01/2019
3	EnzymesIBA 01/2019 - 10/2004
3	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2017 - 09/2012
3	LigandsIBA 08/2016 - 12/2005
3	LaccaseIBA 07/2009 - 11/2003
2	DNA (Deoxyribonucleic Acid)IBA 06/2022 - 01/2022
2	AntioxidantsIBA 02/2022 - 10/2020
2	RNA (Ribonucleic Acid)IBA 01/2022 - 11/2004
2	Amyloid (Amyloid Fibrils)IBA 01/2022 - 01/2017
2	Docetaxel (Taxotere)FDA Link 11/2021 - 01/2021
2	Sunitinib (Sutent)FDA Link 01/2021 - 01/2019
2	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2021 - 01/2020
2	Hormones (Hormone)IBA 10/2020 - 01/2019
2	NitrogenIBA 01/2020 - 01/2019
2	Capsules (Microcapsules)IBA 10/2019 - 11/2003
2	ElementsIBA 04/2019 - 11/2006
2	CarbonIBA 01/2019 - 01/2019
2	AllergensIBA 11/2018 - 03/2018
2	Peptides (Polypeptides)IBA 02/2018 - 01/2009
2	C.I. Fluorescent Brightening Agent 28IBA 01/2018 - 01/2017
2	Angiotensin IIIBA 01/2017 - 08/2014
2	Phosphotransferases (Kinase)IBA 01/2017 - 09/2012
2	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 01/2016 - 02/2014
2	Virulence Factors (Pathogenicity Factors)IBA 11/2006 - 11/2003
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 10/2022
1	HirudinsIBA 05/2022
1	Molecular Chaperones (Chaperone, Molecular)IBA 05/2022
1	corilaginIBA 02/2022
1	6-methyladenineIBA 01/2022
1	Toll-Like Receptor 4IBA 01/2022
1	IntegrinsIBA 01/2022
1	Therapeutic UsesIBA 01/2022
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2022

Therapy/Procedure

17	Therapeutics 10/2022 - 08/2002
6	Immunotherapy 10/2022 - 01/2020
5	Castration 11/2021 - 01/2019
2	Lasers (Laser) 01/2021 - 06/2003
2	Radiotherapy 02/2020 - 01/2020
2	Prostatectomy (Retropubic Prostatectomy) 02/2020 - 01/2020
1	Meridians (Jing Luo) 02/2022